Javier Urzay – Deputy Director, Farmaindustria, Spain
Javier Urzay, deputy director of Farmaindustria, gives an overview of the growth of the pharmaceutical sector in…
Farmaindustria, Spain
Last updated: 01.05.2014
Farmaindustria is the National Trade Association of the Spanish based pharmaceutical industry. It gathers most of the R&D based pharmaceutical companies established in Spain, representing nearly 100 percent of prescription medicines sales in the country.
The pharmaceutical industry is a strategic sector for society, both for the nature of its activity, based in its commitment with healthcare, as well as for its economic and business contribution, with an utmost added value.
The pharmaceutical industry provides society with one of the most precious goods, which most contributes to the welfare and health of the population: medicines. The industry researches, develops, produces and markets pharmaceuticals that relieve maladies, and cures diseases.
The economic contribution of the sector is likewise relevant: it holds the highest productivity rate of the pharmaceutical industry; constitutes a source of qualified, stable and diverse employment (more than 50 percent of employees are women); it is very competitive international wise, with almost 10.000 million USD worth of exports each year; it is also intensive in R&D (almost 1.000 million USD a year; 22 percent of the whole industrial sector). Besides, the pharmaceutical industry is committed with the dynamization of Spanish public biomedical research, and with the Healthcare System in continued training and updating of the knowledge base of its professionals.
Medicines are, probably one of the most regulated sectors, precisely to protect to the maximum level the health of citizens. The State does not only pay for a great part of medicines which are used in the country, but it also decides which medicines are suitable to be sold, how they are manufactured and dispensed, and how much is paid for them.
For all these reasons, Farmaindustria represents member companies before Spanish society and its Public Administrations, collaborates with them, fosters the best of the sector for R&D, conveys the reality of the pharmaceutical industry to public opinion, and offers Members value added services.
Contact Details
C/María de Molina, 54, 7ª
28006 Madrid – España
T. (+34) 91 515 93 50
F. (+34)91 563 73 80
Interviews
Humberto Arnés – Director General, Farmaindustria, Spain
Humberto Arnés, director general at Farmaindustria, Spain’s leading pharmaceutical industry association,…
Interview: Humberto Arnés, Director General, Farmaindustria, Spain
Spain’s pharmaceutical industry has been subject to numerous austerity measures over the past few years as a…
Related
Spain / Grifols looks to Egypt; New Leadership Generation at Almirall; Ferrer’s EIB Loan; Esteve’s European Expansion
The latest from Spanish pharma, including the wide swathe of COVID-19 syringes, vaccines, masks, and tests being…
Spain / Pharma News Roundup September 2020
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19 vaccine trial, the latest…
COVID-19 / Spain’s PharmaMar to Begin Trials for Aplidin
PharmaMar, a Spanish firm, is beginning Phase II clinical trials for its anti-tumour drug Aplidin to treat…
Report / New Spain Pharma Report September 2019 Out Now
Building on the topics covered in our March 2019 report, the latest edition of Healthcare & Life Sciences…
Juan Carlos Moro Rodríguez – CEO Iberia Cluster, DB Schenker
Juan Carlos Moro Rodríguez, CEO for the Iberia Cluster with DB Schenker, discusses the company’s plans to expand…
Company Profile / Jazz Pharmaceuticals Spain: Playing to a Different Beat
Though still one of the younger and lesser-known outfits inhabiting the European drug development landscape,…
Specialising to Succeed in the Spanish Women’s Health Market
In what is a highly competitive and crowded women’s health field in Spain, smaller players are having to be…
Philanthropy / A Boost for Spain’s Out-of-Date Hospital Equipment
Many of the world’s mega-rich are increasingly active philanthropists in the healthcare arena and Spain is no…
Profile / Aspen Spain: Thriving on Change
The global acquisition of GSK’s thrombosis portfolio and subsequent purchase of AstraZeneca’s anaesthesia…
Profile / Isdin's Juan Naya: To Space & Back
Perhaps the only CEO of a dermo-cosmetics company with a PhD in astrophysics and space technology as well as three…
Catalonia: At the Forefront of Spanish Healthcare
The North-Eastern region of Catalonia is one of Spain’s most prosperous and has been allocating increasingly…
Rocco de Bernardis – Managing Director, Johnson & Johnson Medical…
Rocco De Bernardis, managing director for Johnson & Johnson Medical Devices in Spain offers his insights into…
